from canine blood, ≥98%, epidermal cell growth inhibitor, lyophilized powder
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
0.5 mg | CHA.86810-0.5mg | €348.00 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
1 mg | CHA.86810-1mg | €628.00 |
from canine blood, ≥98%, epidermal cell growth inhibitor, lyophilized powder
| CAS Number | 54827-14-4 |
|---|---|
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
| MDL number | MFCD00131139 |
| Assay | ≥98% |
| Form | lyophilized powder |
| Quality level | 200 |
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Chemdor Chemicals L.L.C., Dubai, United Arab Emirates supports structured B2B procurement workflows for Monosialoganglioside GM₃ (CAS 54827-14-4) .
Supporting laboratory, research, and industrial procurement operations across international markets.